Back to top
more

Abbott Laboratories (ABT)

(Delayed Data from NYSE)

$112.73 USD

112.73
3,448,730

+0.12 (0.11%)

Updated Sep 26, 2024 04:00 PM ET

After-Market: $112.69 -0.04 (-0.04%) 5:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.68%
2Buy17.55%
3Hold9.21%
4Sell4.93%
5Strong Sell2.36%
S&P50010.96%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

4-Sell of 5       4  

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

C Value D Growth B Momentum D VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 24% (61 out of 252)

Industry: Medical - Products

Better trading starts here.

Zacks News

Abbott's (ABT) Epic Max Tissue Valve Receives FDA Approval

Abbott's (ABT) Epic Max design optimizes patient blood flow and has a low profile that makes future cardiac interventions simpler.

Abbott (ABT) Outpaces Stock Market Gains: What You Should Know

Abbott (ABT) closed at $98.46 in the latest trading session, marking a +0.42% move from the prior day.

Abbott's (ABT) CardioMEMS Favors Heart Failure Management

Abbott (ABT) announces key findings from meta-analysis, which shows remote pressure monitoring to be a life-extending option among heart failure patients.

Wall Street Analysts See Abbott (ABT) as a Buy: Should You Invest?

According to the average brokerage recommendation (ABR), one should invest in Abbott (ABT). It is debatable whether this highly sought-after metric is effective because Wall Street analysts' recommendations tend to be overly optimistic. Would it be worth investing in the stock?

Here's Why You Should Retain Abbott (ABT) Stock for Now

Investors are optimistic about Abbott (ABT) on continued growth in the core Diagnostics arm.

Abbott (ABT) Stock Moves 0.89%: What You Should Know

Abbott (ABT) closed the most recent trading day at $97.87, moving +0.89% from the previous trading session.

Abbott (ABT) Diabetes Arm Growth Robust Amid Macroeconomic Woes

Abbott (ABT) currently forecasts total organic sales growth, excluding the impact of COVID testing-related sales, to be in the high-single digits in 2023.

Abbott (ABT) Gains But Lags Market: What You Should Know

Abbott (ABT) closed at $98.55 in the latest trading session, marking a +0.37% move from the prior day.

Sheraz Mian headshot

Top Research Reports for AbbVie, NextEra Energy & ConocoPhillips

Today's Research Daily features new research reports on 16 major stocks, including AbbVie Inc. (ABBV), NextEra Energy, Inc. (NEE) and ConocoPhillips (COP).

Abbott (ABT) to Pair CGM Sensors & AID System on FDA Clearance

Abbott Laboratories (ABT) receives FDA clearance for the integration of its iCGM system sensors with automated insulin delivery (AID) systems.

Is Invesco Defensive Equity ETF (DEF) a Strong ETF Right Now?

Smart Beta ETF report for DEF

Abbott (ABT) Stock Sinks As Market Gains: What You Should Know

In the latest trading session, Abbott (ABT) closed at $99.40, marking a -0.58% move from the previous day.

Abbott (ABT) Gets FDA Nod for Alinity I Laboratory Test

Abbott's (ABT) Alinity i TBI lab test provides a new reliable result in 18 minutes to support clinicians in quickly assessing concussion and triaging patients.

Abbott (ABT) Reveals Favorable Data on Tricuspid Regurgitation

Abbott Laboratories (ABT) demonstrates the superiority of the TriClip device in treating patients with severe, symptomatic tricuspid regurgitation.

Zacks Investment Ideas feature highlights: Procter and Gamble, Johnson & Johnson and Abbott Labs

Procter and Gamble, Johnson & Johnson and Abbott Labs have been highlighted in this Investment Ideas article.

Ethan Feller headshot

3 Value Stocks on Sale Now

Growth stocks have clearly led the market thus far in 2023, but will that continue?

Abbott (ABT) Makes Progress in the TAVI Space With Navitor

Results from Abbott's (ABT) PORTICO study support Navitor's recent FDA approval to treat patients with severe aortic stenosis who are at high or extreme risk for open-heart surgery.

Abbott's (ABT) MitraClip Device Shows Favorable Outcome

Abbott's (ABT) landmark COAPT trial demonstrated that MitraClip is safe and effective and can reduce the hospitalization rate.

Should Invesco Defensive Equity ETF (DEF) Be on Your Investing Radar?

Style Box ETF report for DEF

Should You Invest in Abbott (ABT) Based on Bullish Wall Street Views?

According to the average brokerage recommendation (ABR), one should invest in Abbott (ABT). It is debatable whether this highly sought-after metric is effective because Wall Street analysts' recommendations tend to be overly optimistic. Would it be worth investing in the stock?

Abbott (ABT) Outpaces Stock Market Gains: What You Should Know

Abbott (ABT) closed the most recent trading day at $102.63, moving +1.79% from the previous trading session.

Abbott (ABT) Dips More Than Broader Markets: What You Should Know

Abbott (ABT) closed the most recent trading day at $100.83, moving -0.87% from the previous trading session.

Why Is Abbott (ABT) Down 7.7% Since Last Earnings Report?

Abbott (ABT) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Abbott (ABT) Stock Sinks As Market Gains: What You Should Know

In the latest trading session, Abbott (ABT) closed at $102.55, marking a -0.14% move from the previous day.